Intravenous Infusions is trading 9% down at GHS 0.71 as the stock undergoes profit-taking following a period of sharp volatility on the Ghana Stock Exchange.
- The move follows several sessions of significant gains and pullbacks, with the stock recently highlighted for its high volatility and susceptibility to short-term swings.
- No fresh company-specific announcements or regulatory filings have been released, indicating the price action is driven by liquidity dynamics rather than fundamental changes.